logo

For the Inventor, By the Inventor

Metuchen, NJ, United States of America

David Taub

This inventor holds 18 USPTO granted patents, primarily in Immunosuppressive Compounds. Top assignee: Merck + Co., Inc.. Active years: 1976-1993.

IDiyas Innovation Intelligence. (2026). Inventor Profile: David Taub. Retrieved from https://idiyas.com/inventor/david-taub

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 18

% Patents Active = 100.0

Average Co-Inventor Count = 2.5

ph-index = 4

Forward Citations = 90(Granted Patents)


Company Filing History:

goldMedal18 out of 4,770 
 
Merck + Co., Inc.
 patents

Years Active: 1976-1993

Loading Chart...
Areas of Expertise:
Immunosuppressive
Cyclosporin
Amino Acids
Antibacterial Agents
Enzyme Inhibitors
Prostaglandins
Synthesis
Analog
Derivatives
Intermediate
Amino Acid Derivatives
Antihypertensives
18 patents (USPTO):Explore Patents
1. 5214130 - Synthesis of novel immunosuppressive cyclosporin analogs with modified (1993-05-25),
2. 5122511 - Immunosuppressive cyclosporin analogs with modified amino acids at (1992-06-16),
3. 4806680 - 3-halovinylglycine antibacterial agents (1989-02-21),
4. 4727062 - 3-Halovinylglycine antibacterial agents (1988-02-23),
5. 4634716 - Substituted N-carboxymethyl-aminoacylaminoalkanoic acids useful as (1987-01-06),
6. 4626545 - Amino acid derivatives as enzyme inhibitors (1986-12-02),
7. 4401676 - Novel .alpha.-amino acids (1983-08-30),
8. 4396616 - Substituted enantholactam derivatives as antihypertensives (1983-08-02),
9. 4005106 - 3.beta.-[(Methoxalyl)oxy]-2.alpha.-(3-oxo-1-octeny (1977-01-25),
10. 3998849 - 2.alpha.-(2-Carboxy-2-formylethyl (1976-12-21),
11. 3992413 - Intermediates in the synthesis of prostaglandins (1976-11-16),
12. 3992412 - 2.alpha.-(2-Carboxy-2-oxoethyl)-3.beta.-hydroxy-5-oxo-1.beta.-c (1976-11-16),
13. 3992411 - 2.alpha.-Formyl-3.beta.-[(methoxalyl)oxy]-5-oxo-1.beta.-cyclopentanehepta (1976-11-16),
14. 3991083 - 2.alpha.-(2-Loweralkanoyloxy-2-carboxyvinyl)-3.beta.-hydroxy-5-oxo-1.beta.- (1976-11-09),
15. 3987082 - Prostaglandin intermediate (1976-10-19),

Title: The Innovative Journey of David Taub

Introduction: David Taub, a pioneering inventor hailing from Metuchen, NJ (US), has made significant contributions to the world of innovations with his creative mind and dedication to progress.

Latest Patents: David Taub holds several patents in various fields, including technology, healthcare, and consumer products. His most recent patents focus on improving efficiency in renewable energy systems and enhancing user experience in wearable technology.

Career Highlights: Throughout his illustrious career, David Taub has been recognized for his groundbreaking inventions that have revolutionized industries. His work has led to advancements in sustainable energy solutions, medical devices, and smart home technologies.

Collaborations: David Taub has collaborated with leading research institutions, universities, and tech companies to bring his inventions to life. His partnerships have resulted in successful product launches and innovative solutions that have impacted society positively.

Conclusion: David Taub's passion for innovation and commitment to pushing the boundaries of what is possible have solidified his place as a respected inventor in the industry. His relentless pursuit of excellence continues to inspire future generations of inventors to think outside the box and create a better world through their inventions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…